Novartis sells off dry eye disease med Xiidra, other ophthalmology assets to Bausch + Lomb for $2.5B zbecker Fri, 06/30/2023 – 10:29 More: Novartis sells off dry eye disease med Xiidra, other ophthalmology assets to Bausch + Lomb for .5B
read moreAlkermes rebuffs challenge from activist investor Sarissa—for now kdunleavy Fri, 06/30/2023 – 10:10 More: Alkermes rebuffs challenge from activist investor Sarissa—for now Source: fierce
read moreFujifilm Diosynth taps company veteran Petersen to drive CDMO toward $1.4B in annual revenue fkansteiner Fri, 06/30/2023 – 10:00 More: Fujifilm Diosynth taps company veteran Petersen to drive CDMO toward .4B in annual revenue Source: fierce
read moreFierce Pharma Asia—Shionogi’s Qpex buy; Takeda’s rare disease win; AbbVie’s patent suit against BeiGene aliu Fri, 06/30/2023 – 09:24 More: Fierce Pharma Asia—Shionogi's Qpex buy; Takeda's rare disease win; AbbVie's patent suit against BeiGene Source: fierce
read moreFormer Alexion VP, 4 others find their ‘goose’ is cooked with SEC insider trading charges kdunleavy Fri, 06/30/2023 – 08:08 More: Former Alexion VP, 4 others find their 'goose' is cooked with SEC insider trading charges Source: fierce
read morePartnership will establish drug candidates using both laboratory tests and machine-learning More: Edinburgh researchers and LifeArc to boost MND treatment processes Source: News
read more© 1994 - 2024 B.M. Pharmaceuticals